PMC:7646269 / 253-449 JSONTXT

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T5","span":{"begin":33,"end":46},"obj":"Disease"},{"id":"T6","span":{"begin":144,"end":152},"obj":"Disease"},{"id":"T7","span":{"begin":174,"end":187},"obj":"Disease"}],"attributes":[{"id":"A5","pred":"mondo_id","subj":"T5","obj":"http://purl.obolibrary.org/obo/MONDO_0005657"},{"id":"A6","pred":"mondo_id","subj":"T6","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A7","pred":"mondo_id","subj":"T7","obj":"http://purl.obolibrary.org/obo/MONDO_0005657"}],"text":"tical risk of invasive pulmonary aspergillosis (IPA) due to known risk factors.\n\nPatients/Methods\nWe aimed to describe the clinical features of COVID‐19‐associated pulmonary aspergillosis at a sin"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T1","span":{"begin":191,"end":192},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"}],"text":"tical risk of invasive pulmonary aspergillosis (IPA) due to known risk factors.\n\nPatients/Methods\nWe aimed to describe the clinical features of COVID‐19‐associated pulmonary aspergillosis at a sin"}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T1","span":{"begin":48,"end":51},"obj":"Chemical"}],"attributes":[{"id":"A1","pred":"chebi_id","subj":"T1","obj":"http://purl.obolibrary.org/obo/CHEBI_17824"},{"id":"A2","pred":"chebi_id","subj":"T1","obj":"http://purl.obolibrary.org/obo/CHEBI_30802"}],"text":"tical risk of invasive pulmonary aspergillosis (IPA) due to known risk factors.\n\nPatients/Methods\nWe aimed to describe the clinical features of COVID‐19‐associated pulmonary aspergillosis at a sin"}

{"project":"LitCovid-PD-HP","denotations":[{"id":"T2","span":{"begin":14,"end":46},"obj":"Phenotype"},{"id":"T3","span":{"begin":48,"end":51},"obj":"Phenotype"}],"attributes":[{"id":"A2","pred":"hp_id","subj":"T2","obj":"http://purl.obolibrary.org/obo/HP_0020103"},{"id":"A3","pred":"hp_id","subj":"T3","obj":"http://purl.obolibrary.org/obo/HP_0020103"}],"text":"tical risk of invasive pulmonary aspergillosis (IPA) due to known risk factors.\n\nPatients/Methods\nWe aimed to describe the clinical features of COVID‐19‐associated pulmonary aspergillosis at a sin"}

{"project":"LitCovid-sentences","denotations":[{"id":"T8","span":{"begin":81,"end":97},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"tical risk of invasive pulmonary aspergillosis (IPA) due to known risk factors.\n\nPatients/Methods\nWe aimed to describe the clinical features of COVID‐19‐associated pulmonary aspergillosis at a sin"}

{"project":"LitCovid-PubTator","denotations":[{"id":"17","span":{"begin":14,"end":46},"obj":"Disease"},{"id":"19","span":{"begin":81,"end":89},"obj":"Species"},{"id":"27","span":{"begin":144,"end":152},"obj":"Disease"},{"id":"28","span":{"begin":164,"end":187},"obj":"Disease"}],"attributes":[{"id":"A17","pred":"tao:has_database_id","subj":"17","obj":"MESH:D055744"},{"id":"A19","pred":"tao:has_database_id","subj":"19","obj":"Tax:9606"},{"id":"A27","pred":"tao:has_database_id","subj":"27","obj":"MESH:C000657245"},{"id":"A28","pred":"tao:has_database_id","subj":"28","obj":"MESH:D055732"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"tical risk of invasive pulmonary aspergillosis (IPA) due to known risk factors.\n\nPatients/Methods\nWe aimed to describe the clinical features of COVID‐19‐associated pulmonary aspergillosis at a sin"}